A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma

For patients with localized pancreatic cancer with minimal vascular involvement, optimal survivability requires a multidisciplinary approach of surgical resection and systemic chemotherapy. FOLFIRINOX is a combination chemotherapy regimen that offers promising results in the perioperative and metast...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhal, Ruchi, Rogers, Sherise C, Lee, Ji-Hyun, Ramnaraign, Brian, Sahin, Ilyas, Fabregas, Jesus C, Thomas, Ryan M., Hughes, Steven J, Nassour, Ibrahim, Hitchcock, Kathryn, Russell, Karen, Kayaleh, Omar, Turk, Anita, Zlotecki, Robert, DeRemer, David L, George, Thomas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2023
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594143/
https://www.ncbi.nlm.nih.gov/pubmed/37753702
http://dx.doi.org/10.2217/fon-2023-0256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594143/
https://www.ncbi.nlm.nih.gov/pubmed/37753702
http://dx.doi.org/10.2217/fon-2023-0256

Ejemplares similares